Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...
His heart was failing, and his medical team at Ohio's Christ Hospital Heart and Vascular Center warned him that he might not ...
The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...
A medical team at The Christ Hospital Heart and Vascular Center has successfully implanted a new type of artificial heart .
Eko Health announced today that the American Medical Association issued a Category III CPT code for its Sensora platform.
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare’s most fundamental tools.
The smart ring noticed data fluctuations when his resting heart rate elevated ... or an autoimmune disease diagnosis. The ...
Andrew Simpson, CEO of HeartSciences, said, “The inclusion of AI-ECG for reimbursement by CMS represents a significant milestone for commercialization of our products and further validates the ...
Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback